Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2012
02/23/2012US20120047586 Polypeptide having enhanced effector function
02/23/2012US20120046968 Systems and methods for providing a stem cell bank
02/23/2012US20120046645 Identification of antigenic peptides from multiple myeloma cells
02/23/2012US20120046458 Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose
02/23/2012US20120046456 Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose
02/23/2012US20120046346 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
02/23/2012US20120046345 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
02/23/2012US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
02/23/2012US20120046339 Novel chorismate mutase gene from the potato cyst nematode globodera rostochiensis
02/23/2012US20120046309 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
02/23/2012US20120046268 Substituted piperidines as Par-1 Antagonists
02/23/2012US20120046250 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell
02/23/2012US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
02/23/2012US20120046227 Designer osteogenic proteins
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120045836 Enzyme-Based Fed-Batch Technique In Liquid Cultures
02/23/2012US20120045835 Portable device based on immobilized cells for the detection of analytes
02/23/2012US20120045834 Method and apparatus for maintaining microcarrier beads in suspension
02/23/2012US20120045833 Bioreactor, control system and control method thereof
02/23/2012US20120045832 Multipotent neural stem cells
02/23/2012US20120045831 Poly(lactic-glycolic)acid cross linked alendronate (plga-aln) a short term controlled release system for stem cell differentiation and drug delivery
02/23/2012US20120045830 Stem cell aggregate suspension compositions and methods of differentiation thereof
02/23/2012US20120045829 Identification of antigenic peptides from multiple myeloma cells
02/23/2012US20120045828 Apparatus for Magnetic Separation of Cells
02/23/2012US20120045827 Separation of antigen-specific memory b cells with a conjugated biopolymer surface
02/23/2012US20120045818 Plant-Based Production of Heterologous Proteins
02/23/2012US20120045811 EGVII Endoglucanase and Nucleic Acids Encoding the Same
02/23/2012US20120045795 Method for producing a cell capable of high-yield production of heteroproteins
02/23/2012US20120045785 Hybrid Prokaryotic-Eukaryotic Tubulins and Use Thereof
02/23/2012US20120045777 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
02/23/2012US20120045770 Lung tissue model
02/23/2012US20120045764 Method of expanding human hepatocytes in vivo
02/23/2012US20120045763 Antibodies Against Cells of Fetal Origin
02/23/2012US20120045755 Her-2 binding antagonists
02/23/2012US20120045565 Onions With High Storage Ability, High Soluble Solids Content and/or Low Pungency
02/23/2012US20120045549 Novel asparaginases and uses thereof
02/23/2012US20120045514 Anti-cancer microparticle
02/23/2012US20120045512 Methods and substrates for differentiation of neural stem cells
02/23/2012US20120045502 Antagonists of muc1
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/23/2012US20120045473 Biomolecule Surface Display and Uses Thereof
02/23/2012US20120045465 Cancer antigen helper peptide
02/23/2012US20120045464 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
02/23/2012US20120045462 Inflammation Inhibiting Compounds
02/23/2012US20120045460 Methods and compositions for treatment of graft rejection and promotion of graft survival
02/23/2012US20120045459 Methods for Treating Autophagy-Related Disorders
02/23/2012US20120045458 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22
02/23/2012US20120045457 Nontypable haemophilus influenzae antigens
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045448 Trp-p8 active compounds and therapeutic treatment methods
02/23/2012US20120045447 T cell costimulating polypeptides and uses thereof
02/23/2012US20120045443 Agonist anti-trk-c monoclonal antibodies
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
02/23/2012US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045423 Cells expressing TH1 characteristics and cytolytic properties
02/23/2012US20120045421 Methods for the isolation of cardiac stem cells
02/23/2012US20120045419 Methods and uses of hypoxic compartment cells
02/23/2012US20120045417 Methods and compositions for islet cell preservation
02/23/2012US20120045411 Short beta-defensin-derived peptides
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045391 Formulations Targeting IGFBP7 for Diagnosis and Therapy of Cancer
02/23/2012US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor
02/23/2012US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
02/23/2012US20120042889 Cultured tobacco cells as a matrix for consumable products
02/23/2012CA2809255A1 Methods of identifying central memory t cells and obtaining antigen-specific t cell populations
02/23/2012CA2808873A1 Cells expressing th1 characteristics and cytolytic properties
02/23/2012CA2808372A1 Methods of generating oligodendrocytes and cell populations comprising same
02/23/2012CA2807890A1 Process for the preparation of disinfected human cell suspensions
02/23/2012CA2807701A1 Human facilitating cells and uses thereof
02/23/2012CA2807611A1 Method of increasing resistance against fungal infection in transgenic plants by hcp-2-gene
02/23/2012CA2807607A1 Cell culture of growth factor-free adapted cells
02/23/2012CA2807226A1 Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs)
02/23/2012CA2805350A1 Method of increasing resistance against soybean rust in transgenic plants by adr-1-gene
02/22/2012EP2420573A1 Stable artificial bioluminescent enzyme having super-high brightness
02/22/2012EP2420572A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
02/22/2012EP2420571A1 High expression promoter and method for producing gene product using same
02/22/2012EP2420569A1 Method for culturing bone marrow stromal cells and mesenchymal stem cells, and method for producing graft cells for treating central neurological disease
02/22/2012EP2420568A2 Methods and compositions for treatment of bone defects with placental cell populations
02/22/2012EP2420567A2 Methods and compositions for treatment of bone defects with placental cell populations
02/22/2012EP2420566A1 Method of preparing human lung tissue stem cells and method of inducing differentiation into human alveolar epithelial cells
02/22/2012EP2420565A1 Compositions and methods useful for culturing differentiable cells
02/22/2012EP2420564A2 Synthetic surfaces for culturing cells in chemically defined media
02/22/2012EP2420563A1 Method for denucleating nucleated erythrocyte, and denucleation inducer
02/22/2012EP2420516A1 Rapid generation of T cell-independent antibody responses to T cell-dependent antigens
02/22/2012EP2420249A1 Vaccine immunotherapy for immune suppressed patients
02/22/2012EP2419512A1 Method of screening for insulin secretion-potentiating agents
02/22/2012EP2419511A1 Targeted integration into stem cells
02/22/2012EP2419508A1 Method for the induction of a reward response by modulation of dopaminergic systems in the central nervous system
02/22/2012EP2419507A1 Prostate cancer cell lines and their use in screening method
02/22/2012EP2419170A2 Cellular electric stimulation mediated by piezoelectric nanotubes
02/22/2012EP2419113A1 Engineered mesenchymal stem cells and method of using same to treat tumors
02/22/2012EP2010565B1 Method for recombinant protein production in cho cells
02/22/2012EP1930434B1 Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof
02/22/2012EP1789540B9 Non-embryonic totipotent blastomer-like stem cells and methods therefor
02/22/2012EP1740608B1 Modified human growth hormone polypeptides and their uses
02/22/2012EP1388327B1 Artificial kidney having function of metabolizing protein and method of constructing the same
02/22/2012CN1913921B 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法 By targeting the apoptotic expose internal antigens of tumor cells to kill tumor cells of the
02/22/2012CN102361979A Peptide capable of binding to immunoglobulin
1 ... 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 ... 1827